(-0.84%) 5 006.75 points
(-0.72%) 37 733 points
(-0.96%) 17 379 points
(2.10%) $84.47
(0.91%) $1.773
(-0.08%) $2 396.10
(-0.46%) $28.25
(-0.68%) $948.00
(0.13%) $0.940
(0.24%) $11.07
(0.16%) $0.805
(-0.21%) $93.71
-0.58% ¥ 5 120.00
Live Chart Being Loaded With Signals
Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, Canada, and Russia...
Stats | |
---|---|
Today's Volume | 21 200.00 |
Average Volume | 32 345.00 |
Market Cap | 174.88B |
EPS | ¥0 ( 2024-02-07 ) |
Next earnings date | ( ¥0 ) 2024-05-08 |
Last Dividend | ¥215.00 ( 2022-09-29 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 23.34 |
ATR14 | ¥4.96 (0.10%) |
Volume Correlation
Noevir Holdings Co., Ltd. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Noevir Holdings Co., Ltd. Correlation - Currency/Commodity
Noevir Holdings Co., Ltd. Financials
Annual | 2023 |
Revenue: | ¥62.55B |
Gross Profit: | ¥42.56B (68.05 %) |
EPS: | ¥224.64 |
Q4 | 2023 |
Revenue: | ¥15.67B |
Gross Profit: | ¥10.19B (65.00 %) |
EPS: | ¥87.19 |
Q3 | 2023 |
Revenue: | ¥15.99B |
Gross Profit: | ¥11.11B (69.51 %) |
EPS: | ¥59.23 |
Q2 | 2023 |
Revenue: | ¥14.69B |
Gross Profit: | ¥9.90B (67.37 %) |
EPS: | ¥43.68 |
Financial Reports:
No articles found.
Noevir Holdings Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥215.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥36.00 | 2010-09-15 |
Last Dividend | ¥215.00 | 2022-09-29 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | ¥1 556.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.39 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.36 | |
Div. Directional Score | 9.18 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8173.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
7550.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6758.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6099.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
4809.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
4025.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
3242.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
2267.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
9099.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7979.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.119 | 1.500 | 7.62 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.105 | 1.200 | 6.52 | 7.82 | [0 - 0.3] |
returnOnEquityTTM | 0.152 | 1.500 | 9.42 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 1.002 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 3.96 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.20 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 1.918 | 1.500 | 0.454 | 0.681 | [0.2 - 2] |
debtRatioTTM | 0.0124 | -1.500 | 9.79 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -11 230 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 269.79 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 239.78 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0193 | -1.500 | 9.92 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.679 | 1.000 | 2.01 | 2.01 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.178 | 1.000 | 8.43 | 8.43 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 10.33 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.878 | 0.800 | 7.48 | 5.99 | [0.5 - 2] |
Total Score | 10.99 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 24.28 | 1.000 | 7.65 | 0 | [1 - 100] |
returnOnEquityTTM | 0.152 | 2.50 | 9.63 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 239.78 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.13 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 269.79 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.002 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 1.285 | 1.500 | 4.77 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.146 | 1.000 | 8.84 | 0 | [0.1 - 0.5] |
Total Score | 7.36 |
Noevir Holdings Co., Ltd.
Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, Canada, and Russia. The company's Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical & Health Food segment produces and sells Nanten Nodo Ame cough drops; functional drinks, such as the Min Min Da Ha; and over-the-counter pharmaceuticals comprising cold remedies, eye drops, and digestive aids, as well as nutritional supplements, and other products. The company's Other segment sells and leases apparels and aircrafts. The company also produces and sells toiletries; purchases and sells makeup products and vessels; and provides market research services. In addition, it provides air transportation, charter flights, ground handling, and hanger rental services; and aircraft flight training, as well as undertakes aviation-related operations. The company sells its products through drug stores, specialty goods and general merchandise stores, supermarkets, online stores, and convenience stores, as well as approximately 2,000 Noevir beauty studios and own retail stores. Noevir Holdings Co., Ltd. was founded in 1964 and is headquartered in Tokyo, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators